Shouyao Holdings (Beijing) Co. Ltd. A
医疗健康 · 生物科技
Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of drugs in China. The company offers drugs for oncology indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China.
MARKET 市值 6.11B CNY 52W ¥29.71 – ¥56.86
EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG — 营收 YoY 1300.0%
▲ ROE -13.1% 营业利润率 -63.8% 净利润率 -268.8%